| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.26 | 0.02 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |